Kawasaki Disease: Echocardiographic Assessment

Published on 21/06/2015 by admin

Filed under Cardiovascular

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 1159 times

14 Kawasaki Disease

Echocardiographic Assessment

Background

Kawasaki disease is an acute febrile illness that has a systemic vasculitis and can involve the coronary arteries, causing dilation and/or aneurysmal dilation. Diagnosis is by history and clinical examination with supportive laboratory studies. The classic features of Kawasaki disease include fever for at least 5 days, changes in the extremities, rash, bilateral nonexudative conjunctivitis, erythema of the lips and oral mucosa, and cervical lymphadenopathy. Kawasaki disease most frequently occurs in children younger than 5 years of age and has a higher frequency in patients of Asian descent. The etiology of Kawasaki disease is unknown.

In the acute phase of the illness, patients may have pericarditis, myocarditis, and/or endocarditis. After resolution of the fever, there is a vasculitis that can affect the coronary arteries, resulting in ectasia, aneurysm, and/or thrombosis. If aneurysms occur, they tend to regress over time.

Echocardiography (echo) is used to monitor for coronary artery involvement with examinations recommended at the time of diagnosis, 2 weeks from diagnosis, and 6 to 8 weeks after diagnosis, but may be done more frequently if a patient is at high risk for the development of aneurysms (Box 14-1). If the echocardiogram is normal at 6 to 8 weeks, then further follow-up by echo is considered optional. Patients with positive echocardiographic findings will require ongoing follow-up studies.

Overview of Echocardiographic Approach

Because Kawasaki disease can affect the coronary arterial system, echo provides an essential part of the evaluation of patients with Kawasaki disease. The initial echocardiogram should be a complete study to rule out any structural cardiac abnormalities, but also be focused to look at findings seen in Kawasaki disease. Careful examination of the coronary arteries is needed, and all major segments of the coronary arteries should be visualized, if possible. In addition, assessment of global ventricular function, presence of valvar regurgitation, and evaluation for pericardial effusion should be performed (Box 14-2).

Anatomic Imaging

Anatomic imaging in patients with Kawasaki disease focuses on the coronary arteries (Fig. 14-1). However, a complete assessment of the patient needs to be done initially. A complete transthoracic echocardiogram with two-dimensional (2D), spectral, and color Doppler should be performed to assess for any structural cardiac disease. Areas of particular focus are global ventricular function and assessment for focal wall motion abnormalities, coronary artery abnormalities, valve regurgitation, and the presence of a pericardial effusion (Box 14-3).

Coronary abnormalities seen in patients with Kawasaki disease include perivascular brightness, a lack of distal tapering of the coronaries, diffuse dilation (typically referred to as ectasia [Fig. 14-2]), and aneurysmal dilation (Figs. 14-3 and 14-4) of the coronary arteries. Aneurysms are rarely seen before 10 days into the illness. Coronary scarring, calcification, and stenosis are typically seen in later phases of the illness. Thrombosis of the coronary arteries can occur at any time during the illness. Aneurysms can be classified as saccular with equal lateral and axial dimensions giving the appearance of a round bead, fusiform with proximal and distal tapering of the aneurysm giving a more tubelike appearance, or giant where the aneurysm measures more than 8 mm in size (Box 14-4).

Acquisition

Initial echocardiogram is used as a baseline and should be a complete study.

Step 2: Assess Coronary Arteries

image

Figure 14-6 Mean and prediction limits for 2 and 3 standard deviations for size of the LAD (A), proximal RCA (B), and LMCA (C) according to body surface area for children 18 years old. LMCA Z scores should not be based on dimension at orifice and immediate vicinity; enlargement of LMCA secondary to Kawasaki disease usually is associated with ectasia of the LAD, Cx, or both.

(From Newburger JW, Takahashi M, Gerber MA, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: A statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young. American Heart Association. Pediatrics. 2004;114:1708–1733.)

Suggested Reading

1 Baer AZ, Rubin LG, Shapiro CA, Sood SK, Rajan S, Shapir Y, et al. Prevalence of coronary artery lesions on the initial echocardiogram in Kawasaki syndrome. Arch Pediatr Adolesc Med. 2006;160:686-690.

2 Crystal MA, Syan SK, Yeung RS, Dipchand AI, McCrindle BW. Echocardiographic and electrocardiographic trends in children with acute Kawasaki disease. Can J Cardiol. 2008;24:776-780.

3 Fukazawa R, Ogawa S. Long-term prognosis of patients with Kawasaki disease: at risk for future atherosclerosis? J Nippon Med Sch. 2009;76:124-133.

4 Gordon JB, Kahn AM, Burns JC. When children with Kawasaki disease grow up: myocardial and vascular complications in adulthood. J Am Coll Cardiol. 2009;54:1911-1920.

5 Gupta-Malhotra M, Gruber D, Abraham SS, Roman MJ, Zabriskie JB, Hudgins LC, et al. Atherosclerosis in survivors of Kawasaki disease. J Pediatr. 2009;155:572-577.

6 Heuclin T, Dubos F, Hue V, Godart F, Francart C, Vincent P, et al. Increased detection rate of Kawasaki disease using new diagnostic algorithm, including early use of echocardiography. J Pediatr. 2009;155:695. 9.e1

7 JCS Joint Working Group. Guidelines for diagnosis and management of cardiovascular sequelae in Kawasaki disease (JCS 2008)–digest version. Circ J. 2010;74:1989-2020.

8 Mavrogeni S, Papadopoulos G, Karanasios E, Cokkinos DV. How to image Kawasaki disease: a validation of different imaging techniques. Int J Cardiol. 2008;124:27-31.

9 McCrindle BW, Li JS, Minich LL, Colan SD, Atz AM, Takahashi M, et al. Coronary artery involvement in children with Kawasaki disease: risk factors from analysis of serial normalized measurements. Circulation. 2007;116:174-179.

10 McMorrow Tuohy AM, Tani LY, Cetta F, Lewin MB, Eidem BW, Van Buren P, et al. How many echocardiograms are necessary for follow-up evaluation of patients with Kawasaki disease? Am J Cardiol. 2001;88:328-330.

11 Minich LL, Tani LY, Pagotto LT, Young PC, Etheridge SP, Shaddy RE. Usefulness of echocardiography for detection of coronary artery thrombi in patients with Kawasaki disease. Am J Cardiol. 1998;82:1143. 6, A10

12 Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young. American Heart Association. Pediatrics. 2004;114:1708-1733.

13 Ren X, Banker R. Cardiac manifestation of mucocutaneous lymph node syndrome (Kawasaki disease). J Am Coll Cardiol. 2009 Jun 30;54(1):89.

14 Seve P, Stankovic K, Smail A, Durand DV, Marchand G, Broussolle C. Adult Kawasaki disease: report of two cases and literature review. Semin Arthritis Rheum. 2005;34:785-792.